Clinical Trial Update: GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of granulocyte-augmented cord blood transplantation for patients with poor-risk acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Manchester | Conditions: Acute Myeloid Leukemia, Stem Cell Transplantation | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING